NeoGenomics Inc. (NEO) at a glance

NeoGenomics Inc. (NEO) is a Healthcare company. It trades at $10.97. It does not pay a dividend. Vestovix scores it 51/100 overall. Its strongest dimension is Momentum (64/100) and its weakest is Income (40/100).

Price
$10.97
Market cap
n/a
P/E ratio
n/a
Dividend yield
None
Beta
n/a
52-week range
$4.72 to $13.74
Vestovix Score51/ 100How this works
Value
50
Growth
50
Income
40
Safety
60
Momentum
64